These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 18370666)

  • 21. Efficacy of cholesterol uptake inhibition added to statin therapy among subjects following a low-carbohydrate diet: a randomized controlled trial.
    Chirinos JA; Williams MM; Bregman DB; Ashfaq H; Khayyam U; Iqbal N
    Am Heart J; 2010 May; 159(5):918.e1-6. PubMed ID: 20435205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid effects of peroxisome proliferator-activated receptor-δ agonist GW501516 in subjects with low high-density lipoprotein cholesterol: characteristics of metabolic syndrome.
    Olson EJ; Pearce GL; Jones NP; Sprecher DL
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2289-94. PubMed ID: 22814748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Replacement of carbohydrate by protein in a conventional-fat diet reduces cholesterol and triglyceride concentrations in healthy normolipidemic subjects.
    Wolfe BM; Piché LA
    Clin Invest Med; 1999 Aug; 22(4):140-8. PubMed ID: 10497712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
    Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
    Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
    J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beef and soy-based food supplements differentially affect serum lipoprotein-lipid profiles because of changes in carbohydrate intake and novel nutrient intake ratios in older men who resistive-train.
    Haub MD; Wells AM; Campbell WW
    Metabolism; 2005 Jun; 54(6):769-74. PubMed ID: 15931612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Almonds vs complex carbohydrates in a weight reduction program.
    Wien MA; Sabaté JM; Iklé DN; Cole SE; Kandeel FR
    Int J Obes Relat Metab Disord; 2003 Nov; 27(11):1365-72. PubMed ID: 14574348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Experience of a Diet Designed to Reduce Aging.
    Rosedale R; Westman EC; Konhilas JP
    J Appl Res; 2009 Jan; 9(4):159-165. PubMed ID: 20204146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a Lean Mass Hyperresponder Phenotype Is Lacking with Increases in LDL Cholesterol of Clinical Significance in All Categories of Response to a Carbohydrate-Restricted Diet.
    Moore JM; Diefenbach D; Nadendla M; Hiebert N
    Curr Dev Nutr; 2022 May; 6(5):nzac043. PubMed ID: 35669041
    [No Abstract]   [Full Text] [Related]  

  • 30. Editorial: The Effect of Carbohydrate Restriction on Cancer and Metabolic Syndrome.
    Elisia I; Santosa S; Popovich DG; Krystal G
    Front Nutr; 2022; 9():823302. PubMed ID: 35237644
    [No Abstract]   [Full Text] [Related]  

  • 31. How is the Metabolic Syndrome Related to the Dyslipidemia?
    Blaton V
    EJIFCC; 2007 Feb; 18(1):15-22. PubMed ID: 29632463
    [No Abstract]   [Full Text] [Related]  

  • 32. A Man With Dyslipidemia: To Treat Or Not To Treat?
    Teik OH; Sinnathuray AR
    Malays Fam Physician; 2006; 1(1):40-1. PubMed ID: 26998212
    [No Abstract]   [Full Text] [Related]  

  • 33. Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet.
    Volek JS; Phinney SD; Forsythe CE; Quann EE; Wood RJ; Puglisi MJ; Kraemer WJ; Bibus DM; Fernandez ML; Feinman RD
    Lipids; 2009 Apr; 44(4):297-309. PubMed ID: 19082851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes.
    Ajala O; English P; Pinkney J
    Am J Clin Nutr; 2013 Mar; 97(3):505-16. PubMed ID: 23364002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of a very-low-carbohydrate weight loss diet compared with an isocaloric low-fat diet after 12 mo.
    Brinkworth GD; Noakes M; Buckley JD; Keogh JB; Clifton PM
    Am J Clin Nutr; 2009 Jul; 90(1):23-32. PubMed ID: 19439458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of carbohydrate versus fat restriction on metabolic profiles, biomarkers of inflammation and oxidative stress in overweight patients with Type 2 diabetic and coronary heart disease: A randomized clinical trial.
    Raygan F; Bahmani F; Kouchaki E; Aghadavod E; Sharifi S; Akbari E; Heidari A; Asemi Z
    ARYA Atheroscler; 2016 Nov; 12(6):266-273. PubMed ID: 28607566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of the metabolic syndrome and type 2 diabetes through lifestyle modification.
    Magkos F; Yannakoulia M; Chan JL; Mantzoros CS
    Annu Rev Nutr; 2009; 29():223-56. PubMed ID: 19400751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Has carbohydrate-restriction been forgotten as a treatment for diabetes mellitus? A perspective on the ACCORD study design.
    Westman EC; Vernon MC
    Nutr Metab (Lond); 2008 Apr; 5():10. PubMed ID: 18400080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The case for low carbohydrate diets in diabetes management.
    Arora SK; McFarlane SI
    Nutr Metab (Lond); 2005 Jul; 2():16. PubMed ID: 16018812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review on "Atkins Diabetes Revolution: The Groundbreaking Approach to Preventing and Controlling Type 2 Diabetes" by Mary C. Vernon and Jacqueline A. Eberstein.
    Arora S; McFarlane SI
    Nutr Metab (Lond); 2004 Nov; 1(1):14. PubMed ID: 15535891
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.